<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01078051</url>
  </required_header>
  <id_info>
    <org_study_id>2009-0647</org_study_id>
    <nct_id>NCT01078051</nct_id>
  </id_info>
  <brief_title>Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)</brief_title>
  <official_title>Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seung-Jung Park</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CardioVascular Research Foundation, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CardioVascular Research Foundation, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the safety and effectiveness of drug-eluting stent
      implantation compared to optimal medical treatment in patients with chronic total occlusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, two arms, randomized multi-center trial in Asian-pacific region. Following
      angiography, patients with chronic total occlusion (more than 3 months) have documented
      myocardial ischemia or symptoms of angina, and eligible for stenting without any exclusion
      criteria will be randomized 1:1 to: a) drug-eluting stent vs. b) optimal medical treatment.
      All patients will be followed for at least 3 year.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite outcomes of all cause death, myocardial infarction, stroke, and any revascularization for 3 years after randomization</measure>
    <time_frame>at 3 years</time_frame>
    <description>at the median of 3 years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Death (Cardiac death)</measure>
    <time_frame>at 3 years &amp; 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angina class; Quality of life, clinical outcomes at 5 years</measure>
    <time_frame>at 3 years &amp; 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction, stroke,any revascularization, CTO-vessel related revascularization, hospitalization due to acute coronary syndrome, left ventricular ejection fraction</measure>
    <time_frame>at 3 years &amp; 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1284</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Optimal medical therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>optimal medical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>drug-eluting stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cypher, xience, Endeavor, Taxus</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cypher, xience, Endeavor, Taxus</intervention_name>
    <description>all species of drug-eluting stent implantation</description>
    <arm_group_label>drug-eluting stent</arm_group_label>
    <other_name>percutaneous coronary intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>optimal medical therapy</intervention_name>
    <description>optimal medical therapy</description>
    <arm_group_label>Optimal medical therapy</arm_group_label>
    <other_name>intensive medical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical

          1. Patients with angina or silent ischemia and documented ischemia

          2. Patients who are eligible for intracoronary stenting

          3. Age &gt; 18 years

        Angiographic

          1. De novo lesion CTO

          2. Reference vessel size 2.5 mm by visual estimation

          3. At least one CTO lesions located in proximal or mid epicardial coronary artery. (If
             the patient has two CTO lesions, one CTO lesion should be located in proximal or mid
             epicardial coronary artery)

        CTO definition: TIMI flow 0 and estimated duration over 3 months The duration of the
        occlusion was determined by the interval from the last episode of acute coronary syndrome,
        or In patients without a history of acute coronary syndrome, from the first episode of
        effort angina consistent with the location of the occlusion

          1. Angiographically defined total occlusion over 3 months

          2. If no definite symptom with total occlusion, two experienced operators decide CTO in
             consideration of angiographical morphology (degree of calcification, bridging
             collaterals, non-tapered stump, angiographic filling from collaterals)

        Exclusion Criteria:

          1. History of bleeding diathesis or coagulopathy

          2. Pregnant state

          3. Three vessel CTO

          4. Known hypersensitivity or contra-indication to contrast agent and heparin

          5. ST-elevation acute myocardial infarction requiring primary stenting

          6. Characteristics of lesion 1) Left main disease 2) In-stent restenosis 3) Graft vessels
             4) Distal epicardial coronary artery CTO lesions

          7. Hematological disease

          8. Hepatic dysfunction, liver enzyme (ALT and AST) elevation 3 times normal

          9. Renal dysfunction, creatinine more than 2.0

         10. Contraindication to aspirin, clopidogrel or other commercial antiplatelet agent

         11. Left ventricular ejection fraction

         12. Patients who are actively participating in another drug or device investigational
             study, which have not completed the primary endpoint follow-up period.

         13. Non-cardiac co-morbid conditions are present with limited life expectancy or that may
             result in protocol non-compliance (per site investigator's medical judgment).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-Jung Park, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung-Jung Park</last_name>
    <phone>82-2-3010-4812</phone>
    <email>sjpark@amc.seoul.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seung-Whan Lee</last_name>
    <phone>82-2-3010-4812</phone>
    <email>seungwlee@amc.seoul.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ruby Hall Clinic</name>
      <address>
        <city>Pune</city>
        <zip>I</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.S. Hiremath, MD</last_name>
      <email>shirish.hiremath2011@gmail.com</email>
    </contact>
    <investigator>
      <last_name>J.S. Hiremath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medistra Hospital</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teguh Santoso</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sam Anyang Hospital</name>
      <address>
        <city>Anyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Il-Woo Suh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital, Buchen</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nae Hee Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital, Cheonan</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Yong Shin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chungbuk National University Hospital</name>
      <address>
        <city>Cheongju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyung-kuk Hwang, MD</last_name>
      <email>kh3621@chollian.net</email>
    </contact>
    <investigator>
      <last_name>Kyung-kuk Hwang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Chooncheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bong-Ki Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Ho Her</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Si Wan Choi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Daejeon ST.Mary's Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Ho Hur</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GangNeung Asan Hospital</name>
      <address>
        <city>GangNeung</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Sig Cheong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jei Keon Chae</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Kwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Keun Ahn</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dong-A University Medical Center</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moo Hyun Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kook-jin Chun, MD</last_name>
      <email>ptca82@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kook-jin Chun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung-Jung Park, MD,PhD</last_name>
      <phone>2-3010-4812</phone>
      <phone_ext>82</phone_ext>
      <email>sjpark@amc.seoul.kr</email>
    </contact>
    <contact_backup>
      <last_name>Seung-Whan Lee, MD,PhD</last_name>
      <phone>2-3010-4812</phone>
      <phone_ext>82</phone_ext>
      <email>seungwlee@amc.seoul.kr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hallym University Medical Center, Hangang Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min-Kyu Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-young Lee, MD</last_name>
      <email>jyleeheart@naver.com</email>
    </contact>
    <investigator>
      <last_name>Jong-young Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Un Rha</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Kangnam ST.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki-Bae Seung, MD,PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bundang CHA Hospital</name>
      <address>
        <city>Sungnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-wook Lim, MD</last_name>
      <email>swlim@cha.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sang-wook Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Gon Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun-Seok Shin, MD</last_name>
      <email>sesim98@yahoo.co.kr</email>
    </contact>
    <investigator>
      <last_name>Eun-Seok Shin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wonju Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junghan Yoon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Taiwan University hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul-Hsien-Li Kao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shin Kong Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun-Jack Cheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>King chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wasan Udayachalerm</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
    <country>Indonesia</country>
    <country>Korea, Republic of</country>
    <country>Taiwan</country>
    <country>Thailand</country>
  </location_countries>
  <removed_countries>
    <country>China</country>
  </removed_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2010</study_first_posted>
  <last_update_submitted>December 21, 2016</last_update_submitted>
  <last_update_submitted_qc>December 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>CardioVascular Research Foundation, Korea</investigator_affiliation>
    <investigator_full_name>Seung-Jung Park</investigator_full_name>
    <investigator_title>MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine</investigator_title>
  </responsible_party>
  <keyword>chronic total occlusion</keyword>
  <keyword>stent</keyword>
  <keyword>medical therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is not a publicly funded trial.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

